NCT05471310

Brief Summary

Ataxia-telangiectasia (A-T) is a multisystem auto-somal recessive disorder linked to the A-T mutated gene (ATM) on chromosome 11q22-23, and characterized by progressive neural degeneration, immunodeficiency, and progressive ocular motor dysfunction. In previous studies, the quantitative description of the ocular motor deficits from clinical examination was limited to various defects in saccade and gaze control, dysmetric saccades, impairments of smooth pursuit, gaze holding, convergence, vestibular and optokinetic nystagmus slow phases, and cancellation of the vestibulo-ocular reflex. The aim of our research is to add existing findings with quantitative description of oculomotor patterns in A-T patients using videooculography (VOG).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
5

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Mar 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 15, 2021

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2022

Completed
7 days until next milestone

First Submitted

Initial submission to the registry

April 7, 2022

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2022

Completed
22 days until next milestone

First Posted

Study publicly available on registry

July 22, 2022

Completed
Last Updated

July 22, 2022

Status Verified

July 1, 2022

Enrollment Period

1 year

First QC Date

April 7, 2022

Last Update Submit

July 20, 2022

Conditions

Keywords

Eye movementsSaccadesUnstable gaze holdingRehabilitation

Outcome Measures

Primary Outcomes (3)

  • Gaze holding task

    A fixation task in which the subject will require to look at a target-a green circle (diameter \~1) sequentially presented at eccentric (15 rightward and leftward, 8 upward and downward) positions, each eccentric position being sustained for 20 s. Gaze-holding score will be assessed for each circle by approximating the gaze position coordinates by the least squares method to obtain the best correspondence using the fit function. The areas of the obtained ellipses, reflecting the spread of gaze position coordinates, will be determined for each of the four circle positions in each subject. Areas will be expressed in square visual degrees (sq. deg.)

    baseline, during the intervention-rehabilitation course (once)

  • Visual search task

    Ten black circles (diameter \~1) will be presented on the monitor distributed pseudorandomly over the screen. Subjects will be instructed to count silently the number of points and give a verbal response. Study parameters: the performance time, the number of fixations, their durations, the total length of the scanning trajectory, and the saccade amplitude.

    baseline, during the intervention-rehabilitation course (once)

  • Visually guided saccade task

    The subject will be required to follow a target jumping their gaze from one corner of the square to the next as quickly as possible as soon as a circle appeared; saccades will be required in order to do this (An image of a square with side length 10° will be presented on the monitor and a red circle (diameter \~1°) appeared in the corners sequentially in the clockwise direction.) Study parameters: the total number of saccades completed, the proportions of relatively accurate (A in the range 8.5-11.5°), hypometric (short, A \< 8.5°), and hypermetric (long, A \> 11.5°), and corrective saccades (occurring only after dysmetric saccades, 1.5° \< A \< 5°);

    baseline, during the intervention-rehabilitation course (once)

Secondary Outcomes (1)

  • Scale for the assessment and rating of ataxia

    baseline, during the intervention-rehabilitation course (once)

Eligibility Criteria

Age8 Years - 17 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

The young citizens of Russia suffered from ataxia telangiectasia.

You may qualify if:

  • confirmed diagnosis of ataxia telangiectasia,
  • informed consent,
  • stay at the Clinical Research Rehabilitation Center "Russkoe Pole" for 14 days.

You may not qualify if:

  • epilepsy,
  • poor visual acuity, inability to percept from a computer monitor,
  • inability to hold head and posture satisfactory to perform the tasks,
  • difficulty to obtain adequate recordings due to corrective lenses,
  • visual field defects.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Clinical Rehabilitation Research Center "Russkoe pole"

Chekhov, 142321, Russia

Location

MeSH Terms

Conditions

Ataxia TelangiectasiaCerebellar Ataxia

Condition Hierarchy (Ancestors)

Spinocerebellar AtaxiasCerebellar DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesNeurocutaneous SyndromesAtaxiaDyskinesiasNeurologic ManifestationsTelangiectasisVascular DiseasesCardiovascular DiseasesGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesPrimary Immunodeficiency DiseasesDNA Repair-Deficiency DisordersMetabolic DiseasesNutritional and Metabolic DiseasesImmunologic Deficiency SyndromesImmune System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Alexander F. Karelin, PhD

    Clinical Rehabilitation Research Center "Russkoe pole"

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 7, 2022

First Posted

July 22, 2022

Study Start

March 15, 2021

Primary Completion

March 31, 2022

Study Completion

June 30, 2022

Last Updated

July 22, 2022

Record last verified: 2022-07

Locations